Riskpilot← Back to searchSign inGet full accessICF Woundcare Oy
OYDissolvedY-tunnus 2012781-8Juhanilantie 4Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20060 employeeswww.icf.fi
Revenue 2023
EUR 70K
-27% vs 2022
EBITDA margin
20.6%
-49% vs 2022
Equity ratio
89.0%
Financial strength
Net profit 2023
EUR 11K
-50% vs 2022
| Revenue | EUR 70K | -27% |
| EBITDA | EUR 14K | -49% |
| Net profit | EUR 11K | -50% |
| Total assets | EUR 117K | -4% |
| Equity | EUR 104K | +3% |
| Employees | 0 | — |
Legal name
ICF Woundcare Oy
Y-tunnus number
2012781-8
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
16. tammikuuta 2006
Share capital
EUR 8 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-08-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on harjoittaa sairaala-, kuntoutus- ja terveydenhuollon tukku- ja vähittäiskauppaa, maahantuonti- ja agentuuritoimintaa, edellisiin liittyvää vienti-, valmistus-, korjaus- ja huoltotoimintaa sekä konsultointia ja koulutusta. Yhtiö harjoittaa toimintaa koko maassa.
Address
Juhanilantie 4
Phone
+35893462574
Email
olavi.murros@icf.fi
Website
www.icf.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 150 | 145 | 137 | 95 | 70 |
| Staff expenses | −0 | −0 | −0 | — | −0 |
| EBITDA | 25 | −6 | 20 | 28 | 14 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 24 | −6 | 19 | 28 | 14 |
| Net financials | — | — | 0 | −0 | −0 |
| Profit before tax | 24 | −6 | 19 | 28 | 14 |
| Tax | 5 | −0 | 3 | 6 | 3 |
| Net profit | 19 | −6 | 17 | 22 | 11 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 97 | 84 | 93 | 122 | 117 |
| Equity | 88 | 75 | 86 | 101 | 104 |
| Long-term debt | — | — | — | — | 0 |
| Short-term debt | 9 | 9 | 7 | 21 | 13 |
| Total debt | 9 | 9 | 7 | 21 | 13 |
EBITDA margin
20.6%
This company
15.8%
Market median
+30% vs market
20192023
Equity ratio
89.0%
This company
38.2%
Market median
+133% vs market
20192023
Return on equity
10.8%
This company
18.4%
Market median
+41% vs market
20192023
Net profit margin
16.0%
This company
8.1%
Market median
+98% vs market
20192023
Asset turnover
0.60×
This company
1.12×
Market median
-46% vs market
20192023
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20192023
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-08-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
OT Chief Executive Officer | Chief Executive Officer | 2006 |
| Former (2) | ||
EM | Audit | 2022 – 2023 |
IE | Audit | 2012 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2020 | |
| Former (2) | ||
| Board of Directors | 2006 – 2020 | |
| Chairperson | 2006 – 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ICF Woundcare Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Emmi Maria Elina Cavenius | Audit | 0 companies |
| Ilkka Erkki Emil Vairimaa | Audit | 0 companies |
| Olavi Tapio Murros | Chief Executive Officer | 0 companies |
| Anne Marie Tenhunen | Board of Directors | 0 companies |
| Jukka Harri Erik Tenhunen | Chairperson | 0 companies |
| Anna-Liisa Murros | Board of Directors | 0 companies |